Mimedx (MDXG) Preferred Stock Liabilities (2020 - 2023)

Mimedx (MDXG) has 4 years of Preferred Stock Liabilities data on file, last reported at $92.5 million in Q3 2023.

• For the quarter ending Q3 2023, Preferred Stock Liabilities changed 0.0% year-over-year to $92.5 million; the trailing twelve-month figure through Sep 2023 stood at $92.5 million (changed 0.0% YoY), and the FY2022 full-year result was $92.5 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities was little changed at $92.5 million in Q3 2023, from $92.5 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $92.5 million in Q2 2021 to a low of $91.1 million in Q3 2020.
• A 4-year average of $92.3 million and a median of $92.5 million in 2021 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities climbed 1.52% in 2021 and changed 0.0% in 2022, its largest moves.
• Tracing MDXG's Preferred Stock Liabilities over 4 years: stood at $91.6 million in 2020, then increased by 1.01% to $92.5 million in 2021, then changed by 0.0% to $92.5 million in 2022, then changed by 0.0% to $92.5 million in 2023.
• Business Quant data shows MDXG's Preferred Stock Liabilities at $92.5 million in Q3 2023, $92.5 million in Q2 2023, and $92.5 million in Q1 2023.